Search for other papers by Weiwei He in
Google Scholar
PubMed
Search for other papers by Bin Wang in
Google Scholar
PubMed
Search for other papers by Kaida Mu in
Google Scholar
PubMed
Search for other papers by Jing Zhang in
Google Scholar
PubMed
Search for other papers by Yanping Yang in
Google Scholar
PubMed
Search for other papers by Wei Yao in
Google Scholar
PubMed
Search for other papers by Sheli Li in
Google Scholar
PubMed
Search for other papers by Jin-an Zhang in
Google Scholar
PubMed
Introduction In autoimmune thyroid diseases (AITDs), one of the autoimmune diseases, cytokine-mediated immunity play a key role during the pathogenesis and development ( 1 ). AITDs are common endocrine autoimmune diseases with prevalence of
Search for other papers by Yun Cai in
Google Scholar
PubMed
Search for other papers by Jieni Yan in
Google Scholar
PubMed
Search for other papers by Yong Gu in
Google Scholar
PubMed
Search for other papers by Heng Chen in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xinyu Xu in
Google Scholar
PubMed
Search for other papers by Mei Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Xuqin Zheng in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is a common organ-specific autoimmune disorder which includes two main clinical diseases: Graves’ disease (GD) and Hashimoto’s thyroiditis (HT). Both GD and HT share the immunologic manifestation
Search for other papers by Mírian Romitti in
Google Scholar
PubMed
Search for other papers by Vitor C Fabris in
Google Scholar
PubMed
Search for other papers by Patricia K Ziegelmann in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
Search for other papers by Poli Mara Spritzer in
Google Scholar
PubMed
association between PCOS and autoimmune diseases ( 21 , 22 ) and especially autoimmune thyroid diseases (AITD), the most common form of autoimmune disorder, with an estimated prevalence of 5% ( 23 , 24 , 25 ). AITD results from a dysregulation of the
Search for other papers by A Rouland in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by J-C Chauvet-Gelinier in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by A-L Sberna in
Google Scholar
PubMed
Search for other papers by E Crevisy in
Google Scholar
PubMed
Search for other papers by P Buffier in
Google Scholar
PubMed
Search for other papers by T Mouillot in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by J-M Petit in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by B Vergès in
Google Scholar
PubMed
results impossible. Patients with auto-immune thyroid diseases Eighty-five patients with auto-immune thyroid disease (Graves’ disease or Hashimoto’s thyroiditis) were included. These patients were out-patients followed by the physicians in the
AESKU.KIPP Institute, Wendelsheim, Germany
Search for other papers by Aaron Lerner in
Google Scholar
PubMed
Search for other papers by Patricia Jeremias in
Google Scholar
PubMed
Search for other papers by Torsten Matthias in
Google Scholar
PubMed
Introduction Hashimoto's thyroiditis Hashimoto’s thyroiditis (HT) is one of the most common autoimmune endocrine diseases, characterized by an autoimmune-mediated destruction of the thyroid gland. Initially considered a rarity, HT has now
Search for other papers by Jia Liu in
Google Scholar
PubMed
Search for other papers by Min Liu in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Yumei Jia in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
Introduction Autoimmune thyroiditis (AIT) is the most common autoimmune thyroid disease ( 1 , 2 ). Because of varying degree of thyroid destruction, AIT patients manifest with different thyroid function including euthyroidism, subclinical or
2nd Department of Internal Medicine, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Srobarova, Prague, Czech Republic
Search for other papers by T Grimmichova in
Google Scholar
PubMed
Diabetes Centre, Institute for Clinical and Experimental Medicine (IKEM), Videnska, Prague, Czech Republic
Search for other papers by M Haluzik in
Google Scholar
PubMed
Search for other papers by K Vondra in
Google Scholar
PubMed
Search for other papers by P Matucha in
Google Scholar
PubMed
Search for other papers by M Hill in
Google Scholar
PubMed
than men, in autopsy studies the female/male ratio is the same ( 8 ). (4) Autoimmune thyroid disease (AITD). Studies have produced contradictory results and AITD can even be a protective factor in TC progression ( 9 , 10 ). (5) Both iodine deficiency
Search for other papers by John E M Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
North Lakes Clinical, Department of Nuclear Medicine, Medical Department I, Ruhr Center for Rare Diseases (CeSER), 20 Wheatley Avenue, Ilkley LS29 8PT, UK
Search for other papers by Johannes W Dietrich in
Google Scholar
PubMed
Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
aetiology (%) Autoimmune thyroiditis 27% Benign thyroid disease after surgery 32% Thyroid carcinoma a 41% Surgery, radioiodine treatment (%) 73%, 42% BMI (kg/m 2 ) 27.5 (24.1, 30.8) Dose (μg/day) 100 (75, 150) Weight-adjusted daily dose (μg/kg per day) 1
Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China
Search for other papers by Fei Wu in
Google Scholar
PubMed
Search for other papers by Chaoming Mao in
Google Scholar
PubMed
Search for other papers by Xiao Mou in
Google Scholar
PubMed
Search for other papers by Chengcheng Xu in
Google Scholar
PubMed
Search for other papers by Tingting Zheng in
Google Scholar
PubMed
Search for other papers by Ling Bu in
Google Scholar
PubMed
Search for other papers by Xuan Luo in
Google Scholar
PubMed
Search for other papers by Qingyan Lu in
Google Scholar
PubMed
Search for other papers by Xuefeng Wang in
Google Scholar
PubMed
Introduction Hashimoto’s thyroiditis (HT) is a very common organ-specific autoimmune disease in which the Th1-mediated immune response contributes to the destruction of thyroid follicular cells (TFCs) ( 1 ). In recent years, many studies have
Department of Immunology, Nanjing Medical University, Jiangsu, China
Search for other papers by Yun Hu in
Google Scholar
PubMed
Search for other papers by Na Li in
Google Scholar
PubMed
Search for other papers by Peng Jiang in
Google Scholar
PubMed
Search for other papers by Liang Cheng in
Google Scholar
PubMed
Search for other papers by Bo Ding in
Google Scholar
PubMed
Search for other papers by Xiao-Mei Liu in
Google Scholar
PubMed
Search for other papers by Ke He in
Google Scholar
PubMed
Search for other papers by Yun-Qing Zhu in
Google Scholar
PubMed
Search for other papers by Bing-li Liu in
Google Scholar
PubMed
Search for other papers by Xin Cao in
Google Scholar
PubMed
Search for other papers by Hong Zhou in
Google Scholar
PubMed
Search for other papers by Xiao-Ming Mao in
Google Scholar
PubMed
relationship between thyroid nodule and thyroid cancer ( 3 , 4 ). Thyroid nodules are usually accompanied by an increase in thyroglobulin (Tg) ( 5 , 6 ) and autoimmune thyroid diseases (AITDs), especially Hashimoto’s thyroiditis (HT) ( 7 , 8 ). Interestingly